Live News EQUITY FLASH L impact Nov 03, 2026, 03:13 PM UTC Merck Launches Phase 3 Trial of Ohtuvayre for COPD Prevention Merck has launched a Phase 3 trial evaluating Ohtuvayre for preventing COPD exacerbations. MRK SquawkNews Desk